23,516 results on '"EVEROLIMUS"'
Search Results
2. PROMUS PREMIER™ China Post-Approval Study
3. Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029)
4. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
5. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer (ELEVATE)
6. RESTOR: PK/PD mTORi Inhibition in Older Adults (RESTOR)
7. A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
8. Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
9. XIENCE Skypoint Large Vessel Post Approval Study (SPIRIT XLV PAS)
10. Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus
11. A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
12. Study of Ribociclib and Everolimus in HGG and DIPG
13. A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
14. A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
15. Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
16. A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
17. Treg Modulation With CD28 and IL-6 Receptor Antagonists
18. Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
19. Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 (BIOMEDE 2)
20. Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
21. A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
22. SNF Platform Study of HR+/ HER2-advanced Breast Cancer
23. Phase 1b Combo w/ Ribociclib, Alpelisib, or Everolimus
24. Lenvatinib with Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
25. PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
26. A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer (EMBER)
27. Treg Therapy in Subclinical Inflammation in Kidney Transplantation (TASK)
28. Expanding Liver Transplant Immunosuppression Minimization Via Everolimus (ELIMINATE)
29. Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
30. Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients (QIS)
31. Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors (EVACEL)
32. Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
33. Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
34. A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
35. Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (ACTION-1)
36. Everolimus Aging Study (EVERLAST)
37. Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
38. Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer (LEVER)
39. A MolEcularly Guided Anti-Cancer Drug Off-Label Trial (MEGALiT)
40. Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
41. Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping (abemaSNF1/3)
42. Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia. (BK EVER)
43. A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial Carcinoma
44. Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. (SERENA-1)
45. REgulatory T Cell Therapy to Achieve Immunosuppression REduction (RETIRE)
46. Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
47. Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE (COMPOSE)
48. Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus (EXIST-LT)
49. A Phase 0 /II Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
50. ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer (TACTIVE-E)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.